Netscientific Regulatory News (NSCI)

NetScientific plc

("NetScientific" or the "Group")

Appointment to the Board

NetScientific appoints Jonathan Paisner as Non-Executive Director

26 February 2015: NetScientific (AIM: NSCI), the biomedical and healthcare technology group is pleased to announce that Jonathan Paisner will join the Board with immediate effect as a non-executive director.

Jonathan is the founder of LMN Capital Limited, a corporate finance advisor which helps management teams access capital from a wide range of investors. He is also a consultant lawyer at law firm Mathias Gentle Page Hassan and has acted as a consultant to NetScientific. Previously, he was on the board of boutique investment bank Shore Capital. He is being appointed by the Azima Family Trusts pursuant to their rights under NetScientific's Articles of Association to nominate a director.

Commenting on the appointment, Sir Richard Sykes, Executive Chairman of NetScientific, said, "Jonathan's appointment will further strengthen the Board and the Company's position in 2015. His expertise and experience, particularly in accessing capital and structuring deals, will be valuable in advancing the Group's strategy in 2015 and beyond."

The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies. Jonathan Paisner, aged 45 years, has been a director of the following companies during the five years preceding the date of this announcement:

-Ends-

Notes to Editors

About NetScientific

NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website at www.NetScientific.net 

Contact Details